{
    "pmcid": "9294429",
    "qa_pairs": {
        "How do ESM models contribute to the design of SARS-CoV-2 nanobody binders according to the paper?": [
            "By embedding protein sequences into a high-dimensional space to identify potential binding sites.",
            "By directly synthesizing antibodies in a laboratory setting.",
            "By using chemical reactions to alter the structure of existing antibodies.",
            "By employing traditional trial-and-error methods to test antibody efficacy."
        ],
        "How do ESM models facilitate the generative design of antibodies?": [
            "By sampling from the learned latent space to generate novel antibody sequences.",
            "By using a fixed database of existing antibodies to select the best candidates.",
            "By relying solely on experimental data to create new antibody designs.",
            "By predicting antibody sequences without considering their binding properties."
        ],
        "What advantage do ESM models provide in predicting antibody-antigen interactions?": [
            "They enhance predictive capabilities by learning from large datasets of protein sequences.",
            "They allow for direct visualization of antibody-antigen interactions without computational tools.",
            "They eliminate the need for any experimental validation of predicted interactions.",
            "They provide a fixed set of antibody designs that do not require further optimization."
        ],
        "What is a significant challenge mentioned in the paper regarding the use of ESM models in antibody discovery?": [
            "The need for high-quality training datasets and data availability.",
            "The inability of ESM models to process large datasets efficiently.",
            "The lack of integration with any structural prediction tools.",
            "The excessive computational cost associated with ESM models."
        ],
        "What is the primary focus of the paper 'Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery'?": [
            "The transformative role of deep learning in computational antibody design, particularly for therapeutic antibodies.",
            "The development of vaccines using traditional methods against SARS-CoV-2.",
            "The application of CRISPR technology in genetic editing for disease prevention.",
            "The use of quantum computing in solving complex biological problems."
        ]
    }
}